8-K Announcements
6Apr 10, 2026·SEC
Mar 30, 2026·SEC
Mar 12, 2026·SEC
Beneficient (BENF) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
"Beneficient's financial profile remains characterized by extreme volatility, with revenue swings from negative $43.1 million in 2024Q4 to $18.7 million in 2026Q3, complicating the assessment of its core liquidity-provision model. The firm faces significant structural challenges, including a $2.1 billion retained earnings deficit and a consistent inability to generate positive free cash flow over the last ten quarters. Investors should remain cautious as the company's reliance on non-operating mark-to-market adjustments and thin liquidity buffers, such as the $7.9 million cash balance reported in 2026Q3, suggests a high-risk operational environment."
the company's fundamental instability is highlighted by a $2.1 billion accumulated deficit and a consistent failure to generate positive free cash flow across the last ten observed quarters.
Beneficient (BENF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Beneficient (BENF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 17, 2026 | $0.06vs $0.92+93.5% | $25Mvs $12M-309.2% |
| Q4 2025 | Nov 14, 2025 | $2.32vs $2.16-7.4% | $3Mvs $13M-121.3% |
| Q4 2025 | Sep 29, 2025 | $13.08vs $3.44-280.2% | $31Mvs $17M-282.1% |
| Q4 2025 | Sep 24, 2025 | $0.17vs $0.21+181.0% | $198,000vs $17M-98.8% |
Key metrics vs top competitors for Beneficient (BENF)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.70 | $1.96B | 57.36 | 91.97% | -643.95% | 89.34% | — | |
| $23.15 | $1.44B | 12.18 | 50.13% | 50.89% | 11.68% | — | |
| $4.70 | $190.82M | 3.85 | 36.55% | -19.55% | -3.39% | — | |
| $7.40 | $734.21M | 10.28 | 2.2% | 34.83% | 5.84% | — | |
| $15.16 | $603.7M | 3.18 | -20.47% | 173.56% | 34.04% | — | |
| $12.42 | $677.57M | 7.31 | 24.76% | 39.78% | 7.31% | — |
Beneficient (BENF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Beneficient (BENF) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 10, 2026·SEC
Mar 30, 2026·SEC
Mar 12, 2026·SEC
Sep 29, 2025·SEC
Get notified when BENF posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Beneficient (BENF) stock FAQ — growth, dividends, profitability & financials explained
Beneficient (BENF) reported $-14.9M in revenue for fiscal year 2025.
Beneficient (BENF) grew revenue by 92.0% over the past year. This is strong growth.
Beneficient (BENF) reported a net loss of $49.6M for fiscal year 2025.
Beneficient (BENF) has a return on equity (ROE) of 89.3%. This is excellent, indicating efficient use of shareholder capital.
Beneficient (BENF) had negative free cash flow of $43.6M in fiscal year 2025, likely due to heavy capital investments.